Stakeholder engagement in the development of an upper extremity outcome measure for children with rare musculoskeletal conditions
Tóm tắt
Upper extremity (UE) involvement is prevalent in 73% of individuals with arthrogryposis multiplex congenita (AMC), yet no AMC-specific outcome measure exists. When developing a measure specific to a population with a rare musculoskeletal condition, clinicians’ and patients’ perspectives and involvement is a crucial and necessary step. This study sought to determine the most clinically useful items for an outcome measure of UE function for children with AMC as defined by caregivers and clinicians. To ensure the perspectives and needs of caregivers of children with AMC and clinicians were considered in the development of the UE measure for AMC, a Nominal Group technique (NGT) with caregivers of children with AMC (phase 1) followed by a three-round survey with clinicians (phase 2) were carried out. Phase 1: Eleven individuals participated in the nominal group technique and identified 32 items. The most important items were Picking up an object (n = 11), Eating (n = 10), Reaching mouth (n = 10), Getting out of bed (n = 10). Phase 2: Invitations to participate to an online survey was sent to 47 experts in the field of AMC, 20 participants completed round 1, 15 completed round 2 and 13 completed round 3. Throughout the survey, participants were asked about movement required to screen the UE, essential domains to be included in the measure, establishing a scoring guide and identifying tasks associated with joint motion and position. A preliminary version of an UE AMC-specific outcome measure was developed with the help of caregivers’ perspectives and expert opinions. Arthrogryposis multiplex congenita (AMC) is a rare musculoskeletal condition affects the joints and muscles of the body. In about 70% of the cases, it affects the upper extremities (UE). However, there is no specific outcome measure for UE function in children with AMC. An outcome measure refers to a tool or method used to assess and measure the results or effects of a particular treatment, intervention, or condition. It helps healthcare professionals and researchers understand the impact or outcome of a specific situation, such as the level of improvement or changes in a person's health or function. The goal of this study was to develop such a measure while accounting for the perspectives of youth with AMC, their caregivers and clinicians. To achieve this, a study was conducted in two phases. In the first phase, a Nominal Group technique (NGT) was used to gather input from caregivers of children with AMC. Eleven individuals participated and identified 32 items, with the most important being picking up an object, eating, reaching the mouth, and getting out of bed. In the second phase, a three-round survey was sent to 47 experts in the field of AMC, with 20 participants completing the first round, 15 completing the second round, and 13 completing the third round. The survey asked participants about screening UE movement, essential domains to include in the measure, establishing a scoring guide, and identifying tasks associated with joint motion and position. With the help of caregivers’ perspectives and expert opinions, a preliminary version of an UE AMC-specific outcome measure was developed. This measure will be useful in assessing the UE function in children with AMC and will aid clinicians in developing appropriate treatment plans for this rare condition.
Tài liệu tham khảo
Manafo E, Petermann L, Mason-Lai P, Vandall-Walker V. Patient engagement in Canada: a scoping review of the ‘how’ and ‘what’ of patient engagement in health research. Health Res Policy Syst [Internet]. 2018 Feb 7 [cited 2019 Aug 9];16. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5804082/
Chudyk AM, Waldman C, Horrill T, Demczuk L, Shimmin C, Stoddard R, et al. Models and frameworks of patient engagement in health services research: A scoping review protocol. Res Involve Engagem. 2018;4(1):28.
Ruco A, Nichol K. Patient engagement in research and innovation: a new framework. J Med Imaging Radiat Sci. 2016;47(4):290–3.
Canadian Institutes of Health Research Government of Canada. Strategy for Patient-Oriented Research (SPOR) - Patient Engagement Framework [Internet]. 2014 [cited 2019 Aug 12]. http://www.cihr-irsc.gc.ca/e/48413.html
Fitzpatrick R, Davey C, Buxton M, Jones D. Evaluating patient-based outcome measures for use in clinical trials. Health Technol Assess. 1998;2(14):1–74.
Kirwan J, Fries J, Hewlett S, Osborne R. Patient perspective: choosing or developing instruments. J Rheumatol. 2011;38(8):1716–9.
de Vet HC, Terwee CB, Mokkink LB, Knol DL. Measurement in medicine: A practical guide. Cambridge University Press, Cambridge, UK; 2011. 350 p. (Practical guides to biostatistics and epidemiology). http://dx.doi.org/https://doi.org/10.1017/CBO9780511996214
Cachecho S, Elfassy C, Hamdy R, Rosenbaum P, Dahan‐Oliel N. Arthrogryposis multiplex congenita definition: Update using an international consensus-based approach. Am J Med Genet Part C Seminars Med Genet. 2019;1–8.
Wagner LV, Cherry JS, Sawatzky BJ, Fąfara A, Elfassy C, Eriksson M, et al. Rehabilitation across the lifespan for individuals with arthrogryposis. Am J Med Genet Part C Seminars Med Genet. 2019;1–8.
Hall JG. Arthrogryposis (multiple congenital contractures): diagnostic approach to etiology, classification, genetics, and general principles. Eur J Med Genet. 2014;57(8):464–72.
Hamdy R, van Bosse H, Altiok H, Abu-Dalu K, Kotlarsky P, Fafara A, et al. Treatment and outcomes of arthrogryposis in the lower extremity. Am J Med Genet C Semin Med Genet. 2019;181C:372–84.
Oishi S, Agranovich O, Zlotolow D, Wall L, Stutz C, Pajardi G, et al. Treatment and outcomes of arthrogryposis in the upper extremity. Am J Med Genet C Semin Med Genet. 2019;181C(3):363–71.
Hall JG. Pretibial linear vertical creases or indentations (shin dimples) associated with arthrogryposis. Am J Med Genet Part A. 2013;161(4):737–44.
American Occupational Therapy Association (AOTA). Occupational therapy: Improving function while controlling costs. 2019 [cited 2019 Mar 22]. https://www.aota.org/About-Occupational-Therapy/Professionals.aspx
Canadian Association of Occupational Therapists (CAOT). What is occupational therapy? 2016 [cited 2019 Mar 22]. https://www.caot.ca/site/aboutot/whatisot?nav=sidebar
Canada Physiotherapy Association. Description of Physiotherapy in Canada. Ottawa, ON: Canada Physiotherapy Association; 2012 [cited 2020 Mar 22] p. 15. Available from: https://physiotherapy.ca/sites/default/files/site_documents/dopen-en.pdf
Higgins J, Finch L, Kopec J, Mayo N. Development and initial psychometric evaluation of an item bank created to measure upper extremity function in persons after stroke. J Rehabil Med. 2010;42(2):170–8.
Aaron D, Stegink Jansen C. Development of the functional dexterity test (FDT): construction, validity, reliability, and normative data. J Hand Therapy. 2003;12–21.
Wall L, Vuillerman C, Miller P, Bae D, Goldfarb C. Patient-reported outcomes in arthrogryposis. J Pediat Orthopaed. 2020 [cited 2020 Mar 22]; https://oce-ovid-com.proxy3.library.mcgill.ca/article/01241398-900000000-98393/HTML
Hall JG, Agranovich O, Pontén E, van Bosse HJP. Summary of the 2nd international symposium on arthrogryposis, St Petersburg, Russia, September 17–19, 2014. Am J Med Genet Part A. 2015;167(6):1193–5.
Elfassy C, Cachecho S, Snider L, Dahan-Oliel N. Participation among children with arthrogryposis multiplex congenita: a scoping review. Phys Occup Ther Pediatr. 2020;40(6):610–36.
Elfassy C, Darsaklis B, Snider L, Gagnon C, Hamdy R, Dahan-Oliel N. Rehabilitation needs of youth with arthrogryposis multiplex congenita: perspectives from key stakeholders. Disabil Rehabil. 2019;42(16):1–7.
Elfassy C, Cachecho S, Elekanachi R, Araujo C, Dunn T, Higgins J, et al. Pediatric performance-based outcome measures for upper extremity function: Scoping review and linking to the International Classification of Functioning, Disability, and Health. J Hand Therapy. (Submitted)
Centers for Disease Control and Prevention. Gaining Consensus Among Stakeholders Through the Nominal Group Technique [Internet]. 2018 Aug [cited 2020 Mar 12] p. 2. Report No.: 7. https://www.cdc.gov/healthyyouth/evaluation/pdf/brief7.pdf
McMillan SS, King M, Tully MP. How to use the nominal group and Delphi techniques. Int J Clin Pharmacy. 2016. https://doi.org/10.1007/s11096-016-0257-x.
McMillan SS, Kelly F, Sav A, Kendall E, King MA, Whitty JA, et al. Using the nominal group technique: how to analyse across multiple groups. Health Serv Outcomes Res Method. 2014;14(3):92–108.
Ayre C, Scally AJ. Critical values for Lawshe’s content validity ratio: revisiting the original methods of calculation. Meas Eval Couns Dev. 2014;47(1):79–86.
Hoare B, Imms C, Randall M, Carey L. Linking cerebral palsy upper limb measures to the International Classification of Functioning. Disability Health J Rehabil Med. 2011;43(11):987–96.
Wallen M, Stewart K. Grading and quantification of upper extremity function in children with spasticity. Semin Plast Surg. 2016;30(1):5–13.
Vanderhout SM, Smith M, Pallone N, Tingley K, Pugliese M, Chakraborty P, et al. Patient and family engagement in the development of core outcome sets for two rare chronic diseases in children. Res Involv Engagem. 2021;7(1):66.